PCSK9 and pulmonary fibrosis: The expression of PCSK9 transcripts was dramatically attenuated in AT II cells in pulmonary fibrosis (6 donors), pulmonary systemic sclerosis (5 donors), and chronic obstructive pulmonary disease (COPD) (18 donors) compared to healthy condition (4 donors).